These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 23333350)

  • 1. Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction.
    Panlilio LV; Justinova Z; Goldberg SR
    Pharmacol Ther; 2013 Apr; 138(1):84-102. PubMed ID: 23333350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Approaches to Cancer Therapy: Combining Fatty Acid Amide Hydrolase (FAAH) Inhibition with Peroxisome Proliferator-Activated Receptors (PPARs) Activation.
    Brunetti L; Loiodice F; Piemontese L; Tortorella P; Laghezza A
    J Med Chem; 2019 Dec; 62(24):10995-11003. PubMed ID: 31407888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fatty acid amide hydrolase (FAAH) inhibitors on working memory in rats.
    Panlilio LV; Thorndike EB; Nikas SP; Alapafuja SO; Bandiera T; Cravatt BF; Makriyannis A; Piomelli D; Goldberg SR; Justinova Z
    Psychopharmacology (Berl); 2016 May; 233(10):1879-88. PubMed ID: 26558620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors.
    Mazzola C; Medalie J; Scherma M; Panlilio LV; Solinas M; Tanda G; Drago F; Cadet JL; Goldberg SR; Yasar S
    Learn Mem; 2009 May; 16(5):332-7. PubMed ID: 19403796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats.
    Forget B; Guranda M; Gamaleddin I; Goldberg SR; Le Foll B
    Psychopharmacology (Berl); 2016 May; 233(10):1823-8. PubMed ID: 26864774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation.
    Schlosburg JE; Kinsey SG; Lichtman AH
    AAPS J; 2009 Mar; 11(1):39-44. PubMed ID: 19184452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Fatty Acid Amide Hydrolase (FAAH) Inhibitors in Non-Human Primate Models of Nicotine Reward and Relapse.
    Justinova Z; Panlilio LV; Moreno-Sanz G; Redhi GH; Auber A; Secci ME; Mascia P; Bandiera T; Armirotti A; Bertorelli R; Chefer SI; Barnes C; Yasar S; Piomelli D; Goldberg SR
    Neuropsychopharmacology; 2015 Aug; 40(9):2185-97. PubMed ID: 25754762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB₁- and FAAH-independent mechanisms.
    Bosier B; Muccioli GG; Lambert DM
    Br J Pharmacol; 2013 Jun; 169(4):794-807. PubMed ID: 22970888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety.
    Danandeh A; Vozella V; Lim J; Oveisi F; Ramirez GL; Mears D; Wynn G; Piomelli D
    Psychopharmacology (Berl); 2018 Nov; 235(11):3211-3221. PubMed ID: 30251159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro.
    Slivicki RA; Xu Z; Mali SS; Hohmann AG
    Pharmacol Res; 2019 Apr; 142():267-282. PubMed ID: 30739035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat.
    Cippitelli A; Cannella N; Braconi S; Duranti A; Tontini A; Bilbao A; Defonseca FR; Piomelli D; Ciccocioppo R
    Psychopharmacology (Berl); 2008 Jul; 198(4):449-60. PubMed ID: 18446329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of Peroxisome Proliferator Activated Receptors in Multitarget Paradigm Associated with the Endocannabinoid System.
    Lago-Fernandez A; Zarzo-Arias S; Jagerovic N; Morales P
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.
    Fegley D; Gaetani S; Duranti A; Tontini A; Mor M; Tarzia G; Piomelli D
    J Pharmacol Exp Ther; 2005 Apr; 313(1):352-8. PubMed ID: 15579492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of fatty acid amide hydrolase reduces reinstatement of nicotine seeking but not break point for nicotine self-administration--comparison with CB(1) receptor blockade.
    Forget B; Coen KM; Le Foll B
    Psychopharmacology (Berl); 2009 Sep; 205(4):613-24. PubMed ID: 19484221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
    Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
    Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interference with acute nausea and anticipatory nausea in rats by fatty acid amide hydrolase (FAAH) inhibition through a PPARα and CB1 receptor mechanism, respectively: a double dissociation.
    Rock EM; Limebeer CL; Ward JM; Cohen A; Grove K; Niphakis MJ; Cravatt BF; Parker LA
    Psychopharmacology (Berl); 2015 Oct; 232(20):3841-8. PubMed ID: 26297326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE).
    Leuci R; Brunetti L; Laghezza A; Piemontese L; Carrieri A; Pisani L; Tortorella P; Catto M; Loiodice F
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
    Moreira FA; Kaiser N; Monory K; Lutz B
    Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of fatty acid amide hydrolase reduce carrageenan-induced hind paw inflammation in pentobarbital-treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors.
    Holt S; Comelli F; Costa B; Fowler CJ
    Br J Pharmacol; 2005 Oct; 146(3):467-76. PubMed ID: 16100529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of fatty acid amide hydrolase produces PPAR-alpha-mediated analgesia in a rat model of inflammatory pain.
    Sagar DR; Kendall DA; Chapman V
    Br J Pharmacol; 2008 Dec; 155(8):1297-306. PubMed ID: 18724387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.